Details of the Drug Formulations

General Information of Drug (ID: DMVPLNC)

Drug Name
Ingrezza Drug Info
Synonyms
Valbenazine; 1025504-45-3; UNII-54K37P50KH; Valbenazine free base; NBI 98854; 54K37P50KH; 1025504-45-3 (free base); (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl L-valinate; L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-yl ester; Valbenazine [USAN:INN]; L-Valine, (2R,3R,11bR)-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester; ValbenazineNBI-98854; Valbenazine (USAN/INN); GTPL8694; CHEMBL2364639; SCHEMBL15932979; EX-A2002; MFCD28963976; ZINC43195697; CS-5908; DB11915; SB17456; NCGC00522306-02; [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-yl] (2S)-2-amino-3-methylbutanoate; AC-30929; AS-35294; HY-16771; D10675; NBI-98854;NBI98854;NBI 98854; Q27089118; (2R,3R,11bR)-9,10-Dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H- benzo(a)quinolizin-2-yl L-valinate; (S)-2-amino-3-methyl-butyric acid (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-yl ester; [(2R,3R,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl] (2S)-2-amino-3-methylbutanoate; Valine 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester
Indication
Disease Entry ICD 11 Status REF
Tardive dyskinesia 8A02.10 Phase 4 [1]
Tourette syndrome 8A05.00 Phase 2 [2]
Cross-matching ID
PubChem CID
24795069
CAS Number
1025504-45-3
TTD ID
D63WMQ
ACDINA ID
D00715

Full List of Drug Formulations Containing This Drug

Valbenazine 40 mg capsule
Company Formulation ID FDA Description
Neurocrine Biosciences F21828 Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Mannitol; Silicon dioxide; Gelatin; Starch, pregelatinized corn
------------------------------------------------------------------------------------
Valbenazine 80 mg capsule
Company Formulation ID FDA Description
Neurocrine Biosciences F21829 Isomalt; Fd&c red no. 40; Fd&c blue no. 1; Magnesium stearate; Gelatin; Hypromelloses; Microcrystalline cellulose; Starch, pregelatinized corn
------------------------------------------------------------------------------------
Valbenazine Tosylate 40mg capsule
Company Formulation ID FDA Description
Neurocrine F23594 Colloidal Silicon Dioxide; Magnesium Stearate; Mannitol; Pregelatinized Starch; Hypromellose; Isomalt; Magnesium Stearate; Pregelatinized Starch; Silicified Microcrystalline Cellulose
------------------------------------------------------------------------------------
Valbenazine Tosylate 80mg capsule
Company Formulation ID FDA Description
Neurocrine F23595 Hypromellose; Isomalt; Magnesium Stearate; Pregelatinized Starch; Silicified Microcrystalline Cellulose
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT03698331) The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT03732534) Rollover Study for Continuing NBI-98854 Administration in Pediatric Subjects With Tourette Syndrome. U.S. National Institutes of Health.